ECSP16086746A - IMMUNOSUPPRESSOR FORMULATION - Google Patents

IMMUNOSUPPRESSOR FORMULATION

Info

Publication number
ECSP16086746A
ECSP16086746A ECIEPI201686746A ECPI201686746A ECSP16086746A EC SP16086746 A ECSP16086746 A EC SP16086746A EC IEPI201686746 A ECIEPI201686746 A EC IEPI201686746A EC PI201686746 A ECPI201686746 A EC PI201686746A EC SP16086746 A ECSP16086746 A EC SP16086746A
Authority
EC
Ecuador
Prior art keywords
immunosuppressor
formulation
dosage form
siponimod
production
Prior art date
Application number
ECIEPI201686746A
Other languages
Spanish (es)
Inventor
Reynaud Emeric
Michel Rene Bouillot Philippe
Original Assignee
Productos Familia Sa
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Productos Familia Sa, Novartis Ag filed Critical Productos Familia Sa
Publication of ECSP16086746A publication Critical patent/ECSP16086746A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a una forma de dosificación, preferiblemente para la liberación inmediata, que comprende siponimod, un agente protector de humedad y otros excipientes farmacéuticos y métodos para la producción de dicha forma de dosificación.The present invention relates to a dosage form, preferably for immediate release, comprising siponimod, a moisture protecting agent and other pharmaceutical excipients and methods for the production of said dosage form.

ECIEPI201686746A 2014-04-10 2016-11-09 IMMUNOSUPPRESSOR FORMULATION ECSP16086746A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201461997806P 2014-04-10 2014-04-10

Publications (1)

Publication Number Publication Date
ECSP16086746A true ECSP16086746A (en) 2018-05-31

Family

ID=69669398

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201686746A ECSP16086746A (en) 2014-04-10 2016-11-09 IMMUNOSUPPRESSOR FORMULATION

Country Status (1)

Country Link
EC (1) ECSP16086746A (en)

Similar Documents

Publication Publication Date Title
NI201600071A (en) AUTOTAXIN INHIBITOR COMPOUNDS
CL2015002164A1 (en) Combined formulation of two antiviral compounds.
MA50541A (en) PHARMACEUTICAL FORMULATIONS
EA201692043A1 (en) DOSAGE FORM IMMUNODEPRESSANT
CL2016001587A1 (en) Derivative based on 1,2-naphthoquinone and method of preparation thereof.
CY1124490T1 (en) A PROCESS FOR THE PREPARATION OF A DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC
MA42303A (en) PHARMACEUTICAL FORMULATIONS
BR112017005231A2 (en) eutectic formulations of cyclobenzaprine hydrochloride
MA46867A (en) PHARMACEUTICAL FORMULATIONS
UY34786A (en) PROCEDURE FOR THE MANUFACTURE OF A PHARMACEUTICAL FORM INCLUDING NIFEDIPINO AND CANDESARTAN CILEXETILO
NI201600070A (en) AUTOTAXIN TETRAYCLIC INHIBITORS
IL252897A0 (en) Indenyl compounds, pharmaceutical compositions, and medical uses thereof
CO2017001712A2 (en) Biological compound formulations for instillation
EA201890477A1 (en) INCAPSULATED COMPOSITION OF FINGOLIMODA
CL2018003338A1 (en) Physiologically balanced injectable formulations of fosnetupitant.
CR20170125A (en) SOLID PHARMACEUTICAL COMPOSITION INCLUDING AMLODIPINA AND LOSARTÁN
CL2015003460A1 (en) Topical aqueous ophthalmic compositions containing a 1h-indole-1-carboxamide derivative and use thereof for the treatment of an ophthalmic disease
ECSP16086746A (en) IMMUNOSUPPRESSOR FORMULATION
BR112018006206A2 (en) composition, use of a combination, pharmaceutical fixed dosage form, fixed dosage combination, packaging, and use of a fixed dose combination
SG11201700122TA (en) Pharmaceutical compound comprising 13 glycerides, formulation and application thereof
DK3481370T3 (en) PHARMACEUTICAL COMPOSITION INCLUDING BENZYDAMINE
BR112017017774A2 (en) compound, pharmaceutical composition and method of manufacturing a medicament
IN2014CH00035A (en)
MA42111A (en) TOPICAL PHARMACEUTICAL COMPOSITIONS
UA112089C2 (en) SOLID MEDICINAL FORM OF SODIUM AND SOPHODIC EFFECTS OF DOXYLAMINE COMBINED